# Nasonex (Mometasone Furoate Nasal Spray) in Adenoids Hypertrophy in Children (P04367)

> **NCT01098071** · PHASE4 · COMPLETED · sponsor: **Organon and Co** · enrollment: 34 (actual)

## Conditions studied

- Adenoids

## Interventions

- **DRUG:** mometasone furoate nasal spray

## Key facts

- **NCT ID:** NCT01098071
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-08-01
- **Primary completion:** 2009-09-01
- **Final completion:** 2009-09-01
- **Target enrollment:** 34 (ACTUAL)
- **Last updated:** 2024-05-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01098071

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01098071, "Nasonex (Mometasone Furoate Nasal Spray) in Adenoids Hypertrophy in Children (P04367)". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01098071. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*